Jpmorgan Chase & CO Electromed, Inc. Transaction History
Jpmorgan Chase & CO
- $1.1 Trillion
- Q1 2024
A detailed history of Jpmorgan Chase & CO transactions in Electromed, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,148 shares of ELMD stock, worth $17,254. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,148
Previous 34
3276.47%
Holding current value
$17,254
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ELMD
# of Institutions
41Shares Held
2.32MCall Options Held
7.8KPut Options Held
2.1K-
Punch & Associates Investment Management, Inc. Edina, MN374KShares$5.62 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA367KShares$5.52 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX283KShares$4.25 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA214KShares$3.22 Million0.01% of portfolio
-
Mario Gabelli Gamco Investors, Inc. Et Al | Rye, Ny111KShares$1.67 Million0.02% of portfolio
About Electromed, Inc.
- Ticker ELMD
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,492,200
- Market Cap $128M
- Description
- Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consist...